Sumitomo Pharma Revenue

Sumitomo Pharma had revenue of 108.00B JPY in the quarter ending June 30, 2025, with 19.11% growth. This brings the company's revenue in the last twelve months to 416.16B, up 26.28% year-over-year. In the fiscal year ending March 31, 2025, Sumitomo Pharma had annual revenue of 398.83B with 26.79% growth.

Revenue (ttm)

416.16B

Revenue Growth

+26.28%

P/S Ratio

1.32

Revenue / Employee

108.60M

Employees

3,832

Market Cap

548.26B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	398.83B	84.27B	26.79%
Mar 31, 2024	314.56B	-240.99B	-43.38%
Mar 31, 2023	555.54B	-4.49B	-0.80%
Mar 31, 2022	560.04B	44.08B	8.54%
Mar 31, 2021	515.95B	33.22B	6.88%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,196.22B
Takeda Pharmaceutical Company	4,480.25B
Daiichi Sankyo Company	1,924.68B
HOYA Corporation	876.09B
Otsuka Holdings	2,401.70B
Terumo	1,037.94B
Astellas Pharma	1,944.99B
Shionogi &	440.50B

Revenue Rankings